Aura Biosciences Ownership | Who Owns Aura Biosciences?
Aura Biosciences Ownership Summary
Aura Biosciences is owned by 49.47% institutional investors, 1.87% insiders, and 48.67% retail investors. Matrix capital management company, lp is the largest institutional shareholder, holding 10.50% of AURA shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 8.16% of its assets in Aura Biosciences shares.
AURA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Aura Biosciences | 49.47% | 1.87% | 48.67% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Matrix capital management company, lp | 6.92M | 10.50% | $37.73M |
| Frazier life sciences management | 5.10M | 8.79% | $31.52M |
| Adage capital partners gp | 4.88M | 8.41% | $30.17M |
| Long focus capital management | 4.62M | 7.96% | $28.55M |
| Suvretta capital management | 4.37M | 7.54% | $27.02M |
| Blackrock | 3.01M | 6.08% | $22.72M |
| Blackrock funding, inc. /de | 3.56M | 5.40% | $19.40M |
| Medicxi ventures management (jersey) | 3.04M | 4.61% | $16.57M |
| Vanguard group | 2.94M | 4.45% | $16.00M |
| Franklin resources | 2.20M | 3.33% | $11.98M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Matrix capital management company, lp | 6.92M | 65.48% | $37.73M |
| B group | 572.58K | 2.60% | $3.54M |
| Medicxi ventures management (jersey) | 3.04M | 1.98% | $16.57M |
| Acorn capital advisors | 595.74K | 1.87% | $3.68M |
| Regency capital management inc.\de | 538.58K | 1.22% | $2.94M |
| Frazier life sciences management | 5.10M | 0.94% | $31.52M |
| Long focus capital management | 4.62M | 0.94% | $28.55M |
| Suvretta capital management | 4.37M | 0.69% | $27.02M |
| Levin capital strategies | 1.04M | 0.49% | $5.64M |
| Samsara biocapital | 584.85K | 0.47% | $3.61M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 3.01M | 0.00% | 560.52K |
| Blackrock funding, inc. /de | 3.56M | 0.00% | 154.95K |
| Bnp paribas arbitrage, snc | 114.61K | 0.00% | 82.40K |
| Walleye capital | 67.30K | 0.00% | 67.30K |
| Northern trust | 433.64K | 0.00% | 63.17K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Eventide asset management | - | - | -4.08M |
| Ubs group | 171.64K | 0.00% | -725.17K |
| Levin capital strategies | 1.04M | 0.49% | -591.69K |
| Samsara biocapital | 584.85K | 0.47% | -415.15K |
| Ensign peak advisors | - | - | -390.69K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Walleye capital | 67.30K | 0.00% | 67.30K | $415.89K |
| Prelude capital management | 50.00K | 0.02% | 50.00K | $309.00K |
| Susquehanna group, llp | 27.34K | - | 27.34K | $224.74K |
| Highvista strategies | 27.17K | 0.04% | 27.17K | $167.94K |
| Entrypoint capital | 26.30K | 0.06% | 26.30K | $143.34K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Capital performance advisors llp | -25.00 |
| Corecap advisors | -33.00 |
| True wealth design | -36.00 |
| Nisa investment advisors | -36.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 76 | -28.30% | 32,618,162 | -36.85% | 49 | 0.62% | 32 | -40.74% | 28 | 27.27% |
| Sep 30, 2025 | 103 | 7.29% | 51,053,713 | 1.75% | 87 | 1.18% | 53 | -1.85% | 21 | -25.00% |
| Jun 30, 2025 | 101 | 8.60% | 50,603,535 | 53.66% | 87 | 2.02% | 57 | 32.56% | 29 | -3.33% |
| Mar 31, 2025 | 94 | -3.09% | 39,855,409 | 1.03% | 79 | 1.26% | 43 | -27.12% | 30 | 76.47% |
| Dec 31, 2024 | 96 | 11.63% | 39,448,552 | 7.00% | 79 | 1.44% | 57 | 35.71% | 17 | -29.17% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 4.08M | 8.16% | -1.72M |
| Franklin Biotechnology Discv A(acc)USD | 1.47M | 2.36% | -22.83K |
| Vanguard Total Stock Mkt Idx Inv | 1.37M | 2.20% | -30.36K |
| iShares Russell 2000 ETF | 970.88K | 1.56% | - |
| Franklin Biotechnology Discovery A | 820.94K | 1.32% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 427.12K | 0.69% | -194.62K |
| Fidelity Small Cap Index | 377.17K | 0.61% | -93.22K |
| T. Rowe Price Health Sciences | 323.99K | 0.52% | -3.64K |
| iShares Biotechnology ETF | 276.23K | 0.44% | - |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 256.14K | 0.41% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 17, 2026 | Kilroy Conor | See Remarks | Sell | $61.00K |
| Feb 17, 2026 | Plavsic Mark | Chief Technology Officer | Sell | $80.24K |
| Feb 17, 2026 | Hopkins Janet Jill | Chief Medical Officer | Sell | $103.23K |
| Feb 17, 2026 | Elazzouzi Amy | Senior Vice President, Finance | Sell | $43.26K |
| Feb 17, 2026 | de los Pinos Elisabet | See Remarks | Sell | $241.10K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 7 |
| 2025 Q4 | - | 4 |
| 2025 Q3 | - | 1 |
| 2025 Q2 | 4 | 3 |
| 2025 Q1 | - | 6 |
AURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools